NEW YORK CITY EMPLOYEES' RETIREMENT SYSTEM et al v. VALEANT PHARMACEUTICALS INTERNATIONAL, INC. et al

  1. September 26, 2018

    PwC Escapes Valeant Investors' $80B Price-Gouging Suit

    A New Jersey federal judge Wednesday dismissed PricewaterhouseCoopers LLP from a price-gouging suit from Valeant Pharmaceuticals shareholders, finding that the investors failed to allege a motive to commit fraud. 

  2. April 13, 2018

    Funds Fight Bids To Toss $80B Valeant Price-Gouging Suit

    A proposed class of Valeant Pharmaceuticals shareholders told a New Jersey federal judge Thursday that all of the claims against the company, its executives and several banks over a price-gouging scheme that cost shareholders $80 billion were adequately pled, contrary to a volley of partial dismissal bids pushed by the defendants.

  3. January 02, 2018

    Funds Say Valeant Price-Gouging Probe Cost Them $80B

    Valeant Pharmaceuticals International Inc.'s alleged price-gouging scheme cost shareholders more than $80 billion once the scheme came to light, investors said in a suit filed in New Jersey district court Tuesday.

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!